Neuronal phosphorylated RNA-dependent protein kinase in creutzfeldt-jakob disease

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 2, 2009, Pages 190-198

  Paquet, Claire ^a,b,c   Bose, Anindita ^c   Polivka, Marc ^a   Peoc'H, Katell ^b   Brouland, Jean Philippe ^a   Keohane, Catherine ^d   Hugon, Jacques ^b,c   Gray, Françoise ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSTITUT DU FER À MOULIN   (France)

^d University College Cork and INFANT Centre   (Ireland)

Author keywords

Creutzfeldt Jakob disease; Neuronal apoptosis; Phosphorylated RNAYdependent protein kinase; PKR; Prion protein

Indexed keywords

CASPASE 3; CD68 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; PRION PROTEIN; PROTEIN KINASE R; THREONINE;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTOSIS; BRAIN TISSUE; CELL ACTIVATION; CELL LABELING; CELL NUCLEUS; CELL STRESS; CELLULAR DISTRIBUTION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CREUTZFELDT JAKOB DISEASE; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL NECROSIS; NEUROPATHOLOGY; NICK END LABELING; OCCIPITAL CORTEX; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TEMPORAL CORTEX; BRAIN; ENZYMOLOGY; GENETICS; GLIOSIS; METABOLISM; MIDDLE AGED; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PRION;

AGED; AGED, 80 AND OVER; APOPTOSIS; BRAIN; CASPASE 3; CELL NUCLEUS; CREUTZFELDT-JAKOB SYNDROME; EIF-2 KINASE; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; NERVE DEGENERATION; NEURONS; PHOSPHORYLATION; PRIONS; STRESS, PHYSIOLOGICAL;

EID: 64049093243     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318196cd7c     Document Type: Article

References (56)

1. Prusiner SB. Prion biology and diseases. Cold Spring Harbor Monograph Series 41. 2nd ed. Woodbury, NY: Cold Spring Harbor Laboratory Press, 2004
2. Prusiner SB. The prion diseases. Brain Pathol 1998;8:499-513
3. Kovacs GG, Budka H. Prion diseases: From protein to cell pathology. Am J Pathol 2008;172:555-565 [Epub 2008 Feb 2]
4. Hetz C, Soto C. Protein misfolding and disease: The case of prion disorders. Cell Mol Life Sci 2003;60:133-143 (Pubitemid 36223122)
5. Dorandeu A, Wingertsmann L, Chretien F, et al. Neuronal apoptosis in fatal familial insomnia. Brain Pathol 1998;8:531-537
6. Gray F, Chretien F, Adle-Biassette H, et al. Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1999;58:321-328
7. Forloni G, Angeretti N, Chiesa R, et al. Neurotoxicity of a prion protein fragment. Nature 1993;362:543-546
8. Kristiansen M, Messenger MJ, Klohn PC, et al. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem 2005;280:38851-38861
9. Goggin K, Beaudoin S, Grenier C, et al. Prion protein aggresomes are poly(A)+ ribonucleoprotein complexes that induce a PKR-mediated deficient cell stress response. Biochim Biophys Acta 2008;1783: 479-491
10. Kristiansen M, Deriziotis P, Dimcheff DE, et al. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 2007;26: 175-188
11. Kovacs GG, Gelpi E, Strobel T, et al. Involvement of the endosomal- lysosomal system correlates with regional pathology in Creutzfeldt- Jakob disease. J Neuropathol Exp Neurol 2007;66:628-636
12. Stewart RS, Piccardo P, Ghetti B, et al. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J Neurosci 2005;25:3469-3477
13. Li A, Barmada SJ, Roth KA, et al. N-terminally deleted forms of the prion protein activate both Bax-dependent and Bax-independent neurotoxic pathways. J Neurosci 2007;27:852-859
14. Onuki R, Bando Y, Suyama E, et al. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J 2004;23:959-968
15. Shimazawa M, Hara H. Inhibitor of double stranded RNA-dependent protein kinase protects against cell damage induced by ER stress. Neurosci Lett 2006;409:192-195
16. Lindholm D, Wootz H, Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ 2006;13:385-392
17. Yoshida T, Shiraishi T, Horinaka M, et al. Glycosylation modulates TRAIL-R1/death receptor 4 protein: Different regulations of two pro-apoptotic receptors for TRAIL by tunicamycin. Oncol Rep 2007; 18:1239-1242
18. Zhao L, Ackerman SL. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol 2006;18:444-452
19. Peel AL, Bredesen DE. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol Dis 2003;14:52-62
20. Chang RC, Wong AK, Ng HK, et al. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 2002;13:2429-2432
21. Suen KC, Yu MS, So KF, et al. Upstream signaling pathways leading to the activation of double-stranded RNAYdependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J Biol Chem 2003; 278:49819-49827
22. Bando Y, Onuki R, Katayama T, et al. Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem Int 2005; 46:11-18
23. Hu JH, Zhang H, Wagey R, et al. Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J Neurochem 2003;85:432-442
24. Brown AR, Rebus S, McKimmie CS, et al. Gene expression profiling of the preclinical scrapieYinfected hippocampus. Biochem Biophys Res Commun 2005;334:86-95
25. Yoo BC, Krapfenbauer K, Cairns N, et al. Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett 2002;334:196-200
26. Orsi A, Fioriti L, Chiesa R, et al. Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J Biol Chem 2006;281:30431-30438
27. Hetz C, Russelakis-Carneiro M, Maundrell K, et al. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 2003;22:5435-5445
28. Hetz C, Russelakis-Carneiro M, Walchli S, et al. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 2005; 25:2793-2802
29. Apodaca J, Kim I, Rao H. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response. Biochem Biophys Res Commun 2006;347:319-326
30. Ferreiro E, Resende R, Costa R, et al. An endoplasmic-reticulumY specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol Dis 2006;23:669-678
31. Peoc'h K, Manivet P, Beaudry P, et al. Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype. Hum Mutat 2000;15:482
32. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-233
33. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998;391: 96-99
34. Ansari B, Coates PJ, Greenstein BD, et al. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993;170:1-8
35. Paquet C, Privat N, Kaci R, et al. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 2008; 13:13 36.
36. Donze O, Dostie J, Sonenberg N. Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and fas receptor expression. Virology 1999; 256:322-329
37. Garcia MA, Meurs EF, Esteban M. The dsRNA protein kinase PKR: Virus and cell control. Biochimie 2007;89:799-811
38. Peel AL, Rao RV, Cottrell BA, et al. Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. Hum Mol Genet 2001;10: 1531-1538
39. Garcia MA, Gil J, Ventoso I, et al. Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action. Microbiol Mol Biol Rev 2006;70:1032-1060
40. Budihardjo I, Oliver H, Lutter M, et al. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999;15: 269-290
41. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic-reticulumYspecific apoptosis and cytotoxicity by amyloidbeta. Nature 2000;403:98-103
42. Alcazar A, Fando JL, Azuara C, et al. Protein kinase activities associated with ribosomes of developing rat brain. Identification of eukaryotic initiation factor 2 kinases. Int J Dev Neurosci 1986;4:525-535
43. Unterberger U, Hoftberger R, Gelpi E, et al. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol 2006;65:348-357
44. Chang RC, Suen KC, Ma CH, et al. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem 2002; 83:1215-1225
45. Jeffrey IW, Kadereit S, Meurs EF, et al. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp Cell Res 1995;218:17-27
46. Bergeron J, Benlimame N, Zeng-Rong N, et al. Identification of the interferon-inducible double-stranded RNA-dependent protein kinase as a Manivet regulator of cellular response to bulky adducts. Cancer Res 2000;60
47. Wang X, Fan Z, Wang B, et al. Activation of double-stranded RNAY activated protein kinase by mild impairment of oxidative metabolism in neurons. J Neurochem 2007;103:2380-2390
48. Follo MY, Finelli C, Mongiorgi S, et al. PKR is activated in MDS patients and its subcellular localization depends on disease severity. Leukemia 2008 [Epub ahead of print]
49. Page G, Rioux Bilan A, Ingrand S, et al. Activated double-stranded RNAYdependent protein kinase and neuronal death in models of Alzheimer'sY54
50. Hauw JJ, Gray F, Baudrimont M, et al. Cerebellar changes in 50 cases of Creutzfeldt-Jakob disease with emphasis on granule cell atrophy variant. Acta Neuropathol Suppl 1981;7:196-198
51. Grenier C, Bissonnette C, Volkov L, et al. Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells. J Neurochem 2006;97:1456-1466
52. Bacot SM, Lenz P, Frazier-Jessen MR, et al. Activation by prion peptide PrP106-126 induces a NF-kappaBYdriven proinflammatory response in human monocyteYderived dendritic cells. J Leukoc Biol 2003; 74:118-125
53. Fabrizi C, Silei V, Menegazzi M, et al. The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106-126 in human microglia is tumor necrosis factor-alphaYdependent and involves p38 mitogen-activated protein kinase. J Biol Chem 2001; disease (HD) 276:25692-25696
54. Yeung MC, Liu J, Lau AS. An essential role for the interferon-inducible, double-stranded RNAYactivated protein kinase PKR in the tumor necrosis factorYinduced apoptosis in U937 cells. Proc Natl Acad Sci U S A 1996;93:12451-12455
55. Ingrand S, Barrier L, Lafay-Chebassier C, et al. The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation. FEBS Lett 2007; 581:4473-4478
56. Paquet C, Bose A, Polivka M, et al. Neuronal expression of phos-phorylated RNAYdependent protein kinase (PKR) in Creutzfeldt-Jakob Disease (CJD). Clin Neuropathol 2008;27:160